title: What's new, what's next?
authors.affiliation: AIDS Action Committee of Massachusetts, Boston, MA.
authors.forename: D
authors.initials: D
authors.lastname: Fakuda
mesh_terms: D000225:Adenine / Q000031:analogs & derivatives / Q000600:supply & distribution / Q000627:therapeutic use; D019380:Anti-HIV Agents / Q000600:supply & distribution / Q000627:therapeutic use*; D000998:Antiviral Agents; D002219:Carbamates; D003657:Decision Making; D015224:Dideoxynucleosides / Q000627:therapeutic use; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination; D005663:Furans; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D010349:Patient Compliance; D019258:Saquinavir / Q000008:administration & dosage / Q000627:therapeutic use*; D013449:Sulfonamides / Q000627:therapeutic use; D000099227:Abacavir
chemical_list: D000225:Adenine; D019380:Anti-HIV Agents; D000998:Antiviral Agents; D002219:Carbamates; D015224:Dideoxynucleosides; D005663:Furans; D017320:HIV Protease Inhibitors; D006918:Hydroxyurea; D019258:Saquinavir; D013449:Sulfonamides; D000099227:Abacavir; C095108:amprenavir